These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10646847

  • 1. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.
    Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL.
    Cancer Res; 2000 Jan 01; 60(1):35-7. PubMed ID: 10646847
    [Abstract] [Full Text] [Related]

  • 2. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
    Valiente M, Andrés-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R.
    J Biol Chem; 2005 Aug 12; 280(32):28936-43. PubMed ID: 15951562
    [Abstract] [Full Text] [Related]

  • 3. A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains.
    Sotelo NS, Valiente M, Gil A, Pulido R.
    J Cell Biochem; 2012 Aug 12; 113(8):2661-70. PubMed ID: 22434720
    [Abstract] [Full Text] [Related]

  • 4. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
    Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE.
    Proc Natl Acad Sci U S A; 2000 Apr 11; 97(8):4233-8. PubMed ID: 10760291
    [Abstract] [Full Text] [Related]

  • 5. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.
    Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AM.
    Cancer Res; 2001 Jul 01; 61(13):4985-9. PubMed ID: 11431330
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M, Bookstein R.
    Cancer Res; 1999 May 15; 59(10):2318-23. PubMed ID: 10344736
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.
    Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR.
    J Biol Chem; 2001 Dec 28; 276(52):48627-30. PubMed ID: 11707428
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
    Fujii GH, Morimoto AM, Berson AE, Bolen JB.
    Oncogene; 1999 Mar 04; 18(9):1765-9. PubMed ID: 10208437
    [Abstract] [Full Text] [Related]

  • 9. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
    Tanaka M, Koul D, Davies MA, Liebert M, Steck PA, Grossman HB.
    Oncogene; 2000 Nov 09; 19(47):5406-12. PubMed ID: 11103942
    [Abstract] [Full Text] [Related]

  • 10. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H, Zhang X, Fowlkes K, Haluska FG.
    Cancer Res; 2000 Apr 01; 60(7):1800-4. PubMed ID: 10766161
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
    Tolkacheva T, Chan AM.
    Oncogene; 2000 Feb 03; 19(5):680-9. PubMed ID: 10698513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC, Lin SF, Shin SJ, Liu TC, Chang JG, Lee JP.
    Kaohsiung J Med Sci; 2000 Jan 03; 16(1):9-12. PubMed ID: 10741010
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.
    Morimoto AM, Berson AE, Fujii GH, Teng DH, Tavtigian SV, Bookstein R, Steck PA, Bolen JB.
    Oncogene; 1999 Feb 11; 18(6):1261-6. PubMed ID: 10022807
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells.
    Sharrard RM, Maitland NJ.
    Br J Cancer; 2000 Oct 11; 83(8):1102-9. PubMed ID: 10993660
    [Abstract] [Full Text] [Related]

  • 17. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM, Navarro M, Segrelles C, Gómez-Casero E, Jorcano JL.
    Oncogene; 1999 Dec 09; 18(52):7462-8. PubMed ID: 10602505
    [Abstract] [Full Text] [Related]

  • 18. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II, Milchgrub S, Brezinschek R, Virmani A, Gazdar AF, Minna JD.
    Oncogene; 1998 Sep 24; 17(12):1557-65. PubMed ID: 9794233
    [Abstract] [Full Text] [Related]

  • 19. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.
    Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA.
    J Biol Chem; 2000 Jul 14; 275(28):21477-85. PubMed ID: 10748157
    [Abstract] [Full Text] [Related]

  • 20. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA.
    Cancer Res; 1997 Dec 01; 57(23):5221-5. PubMed ID: 9393738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.